These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 485549

  • 1. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P, Leyendecker G.
    Arch Gynecol; 1979 Jul 20; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract] [Full Text] [Related]

  • 2. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec 20; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 3. [HCG in patients with hydatidiform mole or chorionepithelioma].
    Rjosk HK, Gokel JM, Holzmann K.
    Arch Gynecol; 1979 Jul 20; 228(1-4):667-8. PubMed ID: 485551
    [No Abstract] [Full Text] [Related]

  • 4. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun 20; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 5. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G, Pürstner P.
    Geburtshilfe Frauenheilkd; 1979 Aug 20; 39(8):704-8. PubMed ID: 478273
    [Abstract] [Full Text] [Related]

  • 6. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN, Salem HT, Al-Ani AT, Chard T, Huang SC, Ouyang PC, Wei PY, Seppälä M.
    Am J Obstet Gynecol; 1981 Mar 15; 139(6):702-4. PubMed ID: 6971058
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr 15; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 8. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct 15; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K.
    Gynecol Obstet Invest; 1987 Oct 15; 23(3):151-6. PubMed ID: 3036671
    [Abstract] [Full Text] [Related]

  • 10. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM, Seppälä M.
    J Clin Endocrinol Metab; 1980 Jan 15; 50(1):57-61. PubMed ID: 6243133
    [No Abstract] [Full Text] [Related]

  • 11. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973 Jan 15; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 12. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb 15; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 13. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb 15; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar 15; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 15. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N.
    Akush Ginekol (Sofiia); 1989 Mar 15; 28(2):15-9. PubMed ID: 2548413
    [Abstract] [Full Text] [Related]

  • 16. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct 15; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 17. Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma.
    Teoh ES, Das NP, Dawood MY, Ratnam SS.
    Acta Endocrinol (Copenh); 1972 Aug 15; 70(4):791-800. PubMed ID: 5068403
    [No Abstract] [Full Text] [Related]

  • 18. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar 15; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 19. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ, Engvall E, Schlaerth JB, Morrow CP.
    Am J Obstet Gynecol; 1980 Oct 01; 138(3):313-20. PubMed ID: 6251725
    [Abstract] [Full Text] [Related]

  • 20. Quantitative chorionic gonadotrophin; prognostic value in hydatidiform mole and chorionepithelioma.
    DELFS E.
    Obstet Gynecol; 1957 Jan 01; 9(1):1-24. PubMed ID: 13388200
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.